Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down on Analyst Downgrade
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report)’s stock price gapped down prior to trading on Tuesday after Wells Fargo & Company lowered their price target on the stock from $50.00 to $47.00. The stock had previously closed at $35.85, but opened at $32.81. Wells Fargo & Company currently has an overweight rating on the […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report)’s stock price gapped down prior to trading on Tuesday after Wells Fargo & Company lowered their price target on the stock from $50.00 to $47.00. The stock had previously closed at $35.85, but opened at $32.81. Wells Fargo & Company currently has an overweight rating on the […]
